Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8586526 DNA-binding proteins and uses thereof

Patent 8586526 was granted and assigned to Sangamo Biosciences Inc. on November, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8586526

Date of Patent

November 19, 2013

Patent Application Number

13068735

Date Filed

May 17, 2011

Patent Citations Received

‌

US Patent 12129223 Lipids for use in lipid nanoparticle formulations

‌

US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

‌

US Patent 12083188 Engineered DNA binding proteins

‌

US Patent 12102069 NANOS knock-out that ablates germline cells

‌

US Patent 11655275 Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

‌

US Patent 11661612 DNA-binding proteins and uses thereof

‌

US Patent 11690921 Delivery of target specific nucleases

‌

US Patent 11692203 Methods and products for transfecting cells

...

Patent Primary Examiner

‌

Marcela M Cordero Garcia

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8586526 DNA-binding proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API